What's in Barbara Ensoli, MD's pipeline?

Barbara Ensoli, MD has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Barbara Ensoli, MD's portfolio?

Top competitors by shared drug class: Astellas Pharma Global Development, Inc., Bharat Biotech International Limited, Chiang Mai University, Clinical Research Organization, Dhaka, Bangladesh, Cytos Biotechnology AG.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/barbara-ensoli-md.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Barbara Ensoli, MD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Barbara Ensoli, MD pipeline: 1 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Tat	Tat	marketed	Therapeutic vaccine	HIV Tat protein	Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Astellas Pharma Global Development, Inc. · 1 shared drug class
Bharat Biotech International Limited · 1 shared drug class
Chiang Mai University · 1 shared drug class
Clinical Research Organization, Dhaka, Bangladesh · 1 shared drug class
Cytos Biotechnology AG · 1 shared drug class
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
ANRS, Emerging Infectious Diseases · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Barbara Ensoli, MD:

Cite this brief

Drug Landscape (2026). Barbara Ensoli, MD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/barbara-ensoli-md. Accessed 2026-06-10.